2-BENZYL-2-(DIMETHYLAMINO)-1-[4-(MORPHOLIN-4-YL)PHENYL]BUTAN-1-ONE (100 mg) (2-Benzyl-2-(dimethylamino)-1-(4-morpholinophenyl)butan-1-one)

In Stock

Ready to ship

Catalogue No.

1800194

CAS No.

119313-12-1

Molecular Formula

C₂₃H₃₀N₂O₂

Product Type

Pharmaceutical Analytical Impurities

$250.00

Shipping information

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Additional information

Current Lot Information

Current Lot:

F25460

CAS RN®

119313-12-1

Harmonized System (HS) Code *:

29349990

UN No:

N/A

NDC No:

N/A

Molecular Formula

C₂₃H₃₀N₂O₂

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS:

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No	USP Certificates/Product Information Sheets and Valid Use Dates	Valid Use Date	Country of Origin*	Material Origin*
F25460	1800194-F25460	See Product Information Sheet	India	Chemical Synthesis


Lot No F25460	USP Certificates/Product Information Sheets and Valid Use Dates 1800194-F25460
Valid Use Date See Product Information Sheet
Country of Origin* India
Material Origin* Chemical Synthesis

Lot No

F25460

USP Certificates/Product Information Sheets and Valid Use Dates

1800194-F25460

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

Chemical Synthesis

Frequently bought together

2-BENZYL-2-(DIMETHYLAMINO)-1-[4-(MORPHOLIN-4-YL)PHENYL]BUTAN-1-ONE (100 mg) (2-Benzyl-2-(dimethylamino)-1-(4-morpholinophenyl)butan-1-one)

Catalogue No.

1800194

CAS No.

119313-12-1

Molecular Formula

C₂₃H₃₀N₂O₂

Product Type

Pharmaceutical Analytical Impurities

$250.00

4-METHOXY ITRACONAZOLE DERIVATIVE (25 mg) (2-sec-Butyl-4-{4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl}-2H-1,2,4-triazol-3(4H)-one)

Catalogue No.

1A06380

CAS No.

252964-68-4

Molecular Formula

C₂₃H₂₉N₅O₂

Product Type

Pharmaceutical Analytical Impurities

$650.00

RIZATRIPTAN N-OXIDE (25 mg) (2-{5-[(1H-1,2,4-Triazol-1-yl)methyl]-1H-indol-3-yl}-N,N-dimethylethanamine oxide)

Catalogue No.

1A10040

CAS No.

260435-42-5

Molecular Formula

C₁₅H₁₉N₅O

Product Type

Pharmaceutical Analytical Impurities

$750.00

2-BENZYL-2-(DIMETHYLAMINO)-1-[4-(MORPHOLIN-4-YL)PHENYL]BUTAN-1-ONE (100 mg) (2-Benzyl-2-(dimethylamino)-1-(4-morpholinophenyl)butan-1-one)

BUPROPION AMINE TOSYLATE (25 mg) (2-Amino-1-(3-chloro-phenyl)-1-propanone 4-methylbenzenesulfonate)

N-(2-BENZOYLPHENYL)-4-METHYLBENZENESULFONAMIDE (100 mg) (2-(p-Toluenesulfonamido)benzophenone)

17-DESHYDROXYACETYL 17-CARBONYL PREDNISOLONE (25 mg) (11β,17α-dihydroxy-3-oxo-androsta-1,4-diene-17-carboxaldehyde)

17-DEOXY PREDNISOLONE (25 mg) (11β,21-Dihydroxypregna-1,4-diene-3,20-dione)

PREDNIENIC ACID (25 mg) (11β,17α-Dihydroxyandrosta-1,4-diene-3-one 17β-carboxylic acid)

TETRACOSANE (100 mg) (n-Tetracosane)

PALIPERIDONE Z-OXIME (25 mg) ((Z)-3-(2-{4-[(2,4-Difluorophenyl)(hydroxyimino)methyl]piperidin-1-yl}ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one )

HYDROCORTISONE 11,21-DIACETATE (25 mg) (17-Hydroxy-3,20-dioxopregn-4-ene-11ß,21-diyl diacetate)

GLYCERYL 1-PALMITATE (100 mg) (2,3-Dihydroxypropyl palmitate)